Skip to main content
Clinical Trials/NCT03233451
NCT03233451
Unknown
Not Applicable

Effect of Psycho-behavioral Intervention on the Depression, Cardiac Function and Quality of Life in Older Adults With Chronic Heart Failure

Peking University6 sites in 1 country236 target enrollmentAugust 1, 2017
ConditionsDepression

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Depression
Sponsor
Peking University
Enrollment
236
Locations
6
Primary Endpoint
16 Item Quick Inventory of Depressive Symptomatology Self-Report Version
Last Updated
7 years ago

Overview

Brief Summary

The study aims to explore the effectiveness of psycho-behavioral intervention on depressive symptoms among older adults with chronic heart failure. Meanwhile, the effect on cardiac function and quality of life will also be explored.

Detailed Description

Depression has been one of the emerging health concerns for older adults, especially for those with chronic heart failure (CHF). It was about 4-5 times more prevalent among patients with CHF than healthy population and independently associated with poor outcome of CHF. As suggested in the clinical management guideline of CHF, it is imperative to create integrative intervention for older adults with CHF, including timely detection and intervention, and ultimately improving the clinical outcome of CHF. However, the approach appropriate for depression intervention among Chinese older adults has yet been developed. This study aims to explore the effectiveness of psycho-behavioral intervention on depression associated with chronic heart failure in old age.

Registry
clinicaltrials.gov
Start Date
August 1, 2017
End Date
December 31, 2020
Last Updated
7 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Peking University
Responsible Party
Principal Investigator
Principal Investigator

Huali Wang

Principal Investigator

Peking University

Eligibility Criteria

Inclusion Criteria

  • between 60 -85 years old.
  • male or female.
  • Diagnosis with depression as measured with PHQ-9 score of 5 and greater;
  • The subject is diagnosed with chronic heart failure according to their history, symptoms, signs, and adjuvant examinations (eg,echocardiography), in line with the diagnostic criteria for chronic heart failure presented in the China Heart Failure Diagnosis and Treatment Guidelines, with NYHA (New York Heart Association) grade II-III.
  • Reading and writing competency for completing the rating scales.
  • Sufficient physical condition, hearing and vision to ensure the completion of psychological behavior intervention.

Exclusion Criteria

  • Currently taking antidepressant drugs, and drug dose is unstable.
  • With is a serious risk of suicide, suicide attempts and suicidal behavior (HAMD17 score of 30 or above, or suicide subscale score of 3 and above,or suicide subscale score of MINI of 6 or above).
  • Intact cognitive function with CSI-D score of less than
  • Having other major mental disorders, including Alzheimer's disease, schizophrenia, schizoaffective psychiatric disorders, delusional disorders, undefined psychotic disorders, substance and alcohol abuse
  • Planned heart surgery within 9 months.
  • Unable to comply with psychological intervention due to serious physical conditions -

Outcomes

Primary Outcomes

16 Item Quick Inventory of Depressive Symptomatology Self-Report Version

Time Frame: between baseline and week 12

The primary outcome measure is the response rate of depression from baseline to week 12. The response rate was defined as a 50% or greater score reduction on 16 Item Quick Inventory of Depressive Symptomatology-Self-Report. The total score ranges from 0 to 27, with higher scores indicating more severe symptoms.

Secondary Outcomes

  • Geriatric Depression Inventory-Self-Report(between baseline and week 4, 8, 12, 24 and 36)
  • cardiac function(between baseline and week 12, and between baseline and week 36)
  • Minnesota living with heart failure questionnaire(between baseline and week 4, 8, 12, 24 and 36)
  • 16 Item Quick Inventory of Depressive Symptomatology Self-Report Version(between baseline and week 1, 2, 4, 8, 24 and 36)
  • 17-Item Hamilton Rating Scale for Depression(between baseline and week 4, 8, 12, 24 and 36)
  • Beck Depression Inventory II(between baseline and week 1, 2, 4, 8, 12, 24 and 36)
  • amino-terminal fragment of pro-B-type natriuretic peptide (NT-ProBNP)(between baseline and week 12, and between baseline and week 36)

Study Sites (6)

Loading locations...

Similar Trials